Abstract
AimsTo investigate the long-term safety of intravitreal ziv-aflibercept in eyes receiving six or more intravitreal injections of ziv-aflibercept, an off-label substitute to the approved aflibercept.MethodsConsecutive patients with retinal disease receiving...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have